<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
<title>Conmed Corporation — News on 6ix</title>
<link>https://6ix.com/company/conmed-corporation</link>
<description>Latest news and press releases for Conmed Corporation on 6ix.</description>
<language>en-us</language>
<lastBuildDate>Thu, 02 Apr 2026 20:05:00 GMT</lastBuildDate>
<generator>6ix RSS</generator>
<atom:link href="https://6ix.com/rss/company/conmed-corporation" rel="self" type="application/rss+xml" />
<image>
<url>https://6ix-events-pro.s3.amazonaws.com/6ixvideo/logos/org-logo683557a878dffbe2df0ea475.webp</url>
<title>Conmed Corporation</title>
<link>https://6ix.com/company/conmed-corporation</link>
</image>
<item>
<title>CONMED Corporation to Announce First Quarter 2026 Financial Results on April 29, 2026</title>
<link>https://6ix.com/company/conmed-corporation/news/conmed-corporation-to-announce-first-quarter-2026-financial-results-on-april-29-2026</link>
<guid isPermaLink="true">https://6ix.com/company/conmed-corporation/news/conmed-corporation-to-announce-first-quarter-2026-financial-results-on-april-29-2026</guid>
<pubDate>Thu, 02 Apr 2026 20:05:00 GMT</pubDate>
<description>LARGO, Fla., April 02, 2026--CONMED Corporation (NYSE: CNMD) today announced that it will report financial results for the first quarter 2026 after the market close on Wednesday, April 29, 2026. The Company’s management will host a conference call at 4:30 p.m. ET that same day to discuss the results.</description>
</item>
<item>
<title>Micro-Tech Endoscopy Signs Definitive Agreement to Acquire Duraclip™, Precisor®, and Optibite® Product Lines from CONMED</title>
<link>https://6ix.com/company/conmed-corporation/news/micro-tech-endoscopy-signs-definitive-agreement-to-acquire-duracliptm-precisorr-and-optibiter-product-lines-from-conmed</link>
<guid isPermaLink="true">https://6ix.com/company/conmed-corporation/news/micro-tech-endoscopy-signs-definitive-agreement-to-acquire-duracliptm-precisorr-and-optibiter-product-lines-from-conmed</guid>
<pubDate>Wed, 18 Mar 2026 14:00:00 GMT</pubDate>
<description>Micro-Tech Endoscopy today announced that it has entered into a definitive agreement to acquire the global distribution rights for the Duraclip™, Precisor®, and Optibite® product lines from CONMED Corporation and which CONMED has sold on behalf of Micro-Tech Endoscopy for over a decade.</description>
</item>
<item>
<title>CONMED Corporation Announces Fourth Quarter and Full-Year 2025 Financial Results</title>
<link>https://6ix.com/company/conmed-corporation/news/conmed-corporation-announces-fourth-quarter-210500162</link>
<guid isPermaLink="true">https://6ix.com/company/conmed-corporation/news/conmed-corporation-announces-fourth-quarter-210500162</guid>
<pubDate>Wed, 28 Jan 2026 21:05:00 GMT</pubDate>
<description>LARGO, Fla., January 28, 2026--CONMED Corporation (NYSE: CNMD) today announced financial results for the fourth quarter and full-year ended December 31, 2025.</description>
</item>
<item>
<title>CONMED Corporation Announces Chief Financial Officer Transition</title>
<link>https://6ix.com/company/conmed-corporation/news/conmed-corporation-announces-chief-financial-215500645</link>
<guid isPermaLink="true">https://6ix.com/company/conmed-corporation/news/conmed-corporation-announces-chief-financial-215500645</guid>
<pubDate>Thu, 08 Jan 2026 21:55:00 GMT</pubDate>
<description>LARGO, Fla., January 08, 2026--CONMED Corporation (NYSE: CNMD) today announced the departure of Todd Garner from his role as Chief Financial Officer effective March 15, 2026. To ensure a smooth and orderly transition, Mr. Garner will remain with the Company in an advisory capacity through November 2, 2026.</description>
</item>
<item>
<title>CONMED Corporation to Present at the 44th Annual J.P. Morgan Healthcare Conference</title>
<link>https://6ix.com/company/conmed-corporation/news/conmed-corporation-present-44th-annual-211000996</link>
<guid isPermaLink="true">https://6ix.com/company/conmed-corporation/news/conmed-corporation-present-44th-annual-211000996</guid>
<pubDate>Mon, 05 Jan 2026 21:10:00 GMT</pubDate>
<description>LARGO, Fla., January 05, 2026--CONMED Corporation (NYSE: CNMD) today announced that Patrick J. Beyer, President and Chief Executive Officer, and Todd W. Garner, Executive Vice President and Chief Financial Officer, will present at the 44th Annual J.P. Morgan Healthcare Conference at 3:00 p.m. PT (6:00 p.m. ET) on Monday, January 12, 2026 in San Francisco, CA.</description>
</item>
<item>
<title>CONMED Corporation to Announce Fourth Quarter 2025 Financial Results on January 28, 2026</title>
<link>https://6ix.com/company/conmed-corporation/news/conmed-corporation-announce-fourth-quarter-210500164</link>
<guid isPermaLink="true">https://6ix.com/company/conmed-corporation/news/conmed-corporation-announce-fourth-quarter-210500164</guid>
<pubDate>Mon, 05 Jan 2026 21:05:00 GMT</pubDate>
<description>LARGO, Fla., January 05, 2026--CONMED Corporation (NYSE: CNMD) today announced that it will report financial results for the fourth quarter 2025 after the market close on Wednesday, January 28, 2026. The Company’s management will host a conference call at 4:30 p.m. ET that same day to discuss the results.</description>
</item>
<item>
<title>CONMED Corporation Announces Strategic Exit from Gastroenterology Product Lines</title>
<link>https://6ix.com/company/conmed-corporation/news/conmed-corporation-announces-strategic-exit-130000599</link>
<guid isPermaLink="true">https://6ix.com/company/conmed-corporation/news/conmed-corporation-announces-strategic-exit-130000599</guid>
<pubDate>Fri, 05 Dec 2025 13:00:00 GMT</pubDate>
<description>LARGO, Fla., December 05, 2025--CONMED Corporation (NYSE: CNMD) today announced its intention to exit its gastroenterology product lines as part of its broader portfolio optimization strategy. This exit allows CONMED to fully align operations and resources within its core markets—minimally invasive, robotic, and laparoscopic surgery, smoke evacuation, and the surgical treatment of orthopedic soft tissue repair.</description>
</item>
<item>
<title>Olympus, Gore, and ConMed Announce Transition of Commercial Support for the GORE® VIABIL® Biliary Endoprosthesis in the United States</title>
<link>https://6ix.com/company/conmed-corporation/news/olympus-gore-and-conmed-announce-transition-of-commercial-support-for-the-gorer-viabilr-biliary-endoprosthesis-in-the-united-states</link>
<guid isPermaLink="true">https://6ix.com/company/conmed-corporation/news/olympus-gore-and-conmed-announce-transition-of-commercial-support-for-the-gorer-viabilr-biliary-endoprosthesis-in-the-united-states</guid>
<pubDate>Fri, 05 Dec 2025 13:00:00 GMT</pubDate>
<description>Olympus Corporation ("Olympus"), W. L. Gore & Associates, Inc. ("Gore"), and ConMed Corporation ("ConMed") jointly announced today the upcoming transition of commercial support and distribution for the GORE® VIABIL® Biliary Endoprosthesis for endoscopic placement ("VIABIL® device") in the United States.</description>
</item>
<item>
<title>CONMED Corporation Announces Third Quarter 2025 Financial Results</title>
<link>https://6ix.com/company/conmed-corporation/news/conmed-corporation-announces-third-quarter-210500161</link>
<guid isPermaLink="true">https://6ix.com/company/conmed-corporation/news/conmed-corporation-announces-third-quarter-210500161</guid>
<pubDate>Wed, 05 Nov 2025 21:05:00 GMT</pubDate>
<description>LARGO, Fla., November 05, 2025--CONMED Corporation (NYSE: CNMD) today announced financial results for the third quarter ended September 30, 2025.</description>
</item>
<item>
<title>CONMED Corporation to Announce Third Quarter 2025 Financial Results on November 5, 2025</title>
<link>https://6ix.com/company/conmed-corporation/news/conmed-corporation-announce-third-quarter-200500120</link>
<guid isPermaLink="true">https://6ix.com/company/conmed-corporation/news/conmed-corporation-announce-third-quarter-200500120</guid>
<pubDate>Thu, 02 Oct 2025 20:05:00 GMT</pubDate>
<description>LARGO, Fla., October 02, 2025--CONMED Corporation (NYSE: CNMD) today announced that it will report financial results for the third quarter 2025 after the market close on Wednesday, November 5, 2025. The Company’s management will host a conference call at 4:30 p.m. ET that same day to discuss the results.</description>
</item>
<item>
<title>CONMED Corporation Adds Kim Kelderman to its Board of Directors</title>
<link>https://6ix.com/company/conmed-corporation/news/conmed-corporation-adds-kim-kelderman-200500696</link>
<guid isPermaLink="true">https://6ix.com/company/conmed-corporation/news/conmed-corporation-adds-kim-kelderman-200500696</guid>
<pubDate>Tue, 09 Sep 2025 20:05:00 GMT</pubDate>
<description>LARGO, Fla., September 09, 2025--CONMED Corporation (NYSE: CNMD) today announced that Kim Kelderman will be joining its Board of Directors effective September 8, 2025.</description>
</item>
<item>
<title>CONMED Corporation Announces Quarterly Cash Dividend</title>
<link>https://6ix.com/company/conmed-corporation/news/conmed-corporation-announces-quarterly-cash-110000915</link>
<guid isPermaLink="true">https://6ix.com/company/conmed-corporation/news/conmed-corporation-announces-quarterly-cash-110000915</guid>
<pubDate>Fri, 08 Aug 2025 11:00:00 GMT</pubDate>
<description>LARGO, Fla., August 08, 2025--CONMED Corporation (NYSE: CNMD) today announced that its Board of Directors declared a quarterly cash dividend of $0.20 per share on August 7, 2025, payable on October 3, 2025, to all shareholders of record as of September 15, 2025.</description>
</item>
<item>
<title>CONMED Corporation Announces Second Quarter 2025 Financial Results</title>
<link>https://6ix.com/company/conmed-corporation/news/conmed-corporation-announces-second-quarter-200500895</link>
<guid isPermaLink="true">https://6ix.com/company/conmed-corporation/news/conmed-corporation-announces-second-quarter-200500895</guid>
<pubDate>Wed, 30 Jul 2025 20:05:00 GMT</pubDate>
<description>LARGO, Fla., July 30, 2025--CONMED Corporation (NYSE: CNMD) today announced financial results for the second quarter ended June 30, 2025.</description>
</item>
<item>
<title>Martha Aronson to Step Down from CONMED Board of Directors Following Appointment as President and Chief Executive Officer of Merit Medical Systems, Inc.</title>
<link>https://6ix.com/company/conmed-corporation/news/martha-aronson-step-down-conmed-210000941</link>
<guid isPermaLink="true">https://6ix.com/company/conmed-corporation/news/martha-aronson-step-down-conmed-210000941</guid>
<pubDate>Mon, 07 Jul 2025 21:00:00 GMT</pubDate>
<description>LARGO, Fla., July 07, 2025--CONMED Corporation (NYSE: CNMD) today announced that Martha Aronson will be stepping down from the company’s Board of Directors to assume the role of President and Chief Executive Officer at Merit Medical, a global leader in the development, manufacture and distribution of proprietary medical devices. Mrs. Aronson’s resignation from the Board will be effective July 7, 2025, as she transitions to her new leadership responsibilities.</description>
</item>
<item>
<title>CONMED Corporation to Announce Second Quarter 2025 Financial Results on July 30, 2025</title>
<link>https://6ix.com/company/conmed-corporation/news/conmed-corporation-announce-second-quarter-200500538</link>
<guid isPermaLink="true">https://6ix.com/company/conmed-corporation/news/conmed-corporation-announce-second-quarter-200500538</guid>
<pubDate>Wed, 02 Jul 2025 20:05:00 GMT</pubDate>
<description>LARGO, Fla., July 02, 2025--CONMED Corporation (NYSE: CNMD) today announced that it will report financial results for the second quarter 2025 after the market close on Wednesday, July 30, 2025. The Company’s management will host a conference call at 4:30 p.m. ET that same day to discuss the results.</description>
</item>
<item>
<title>CONMED Corporation Appoints LaVerne Council as Chair of the Board of Directors</title>
<link>https://6ix.com/company/conmed-corporation/news/conmed-corporation-appoints-laverne-council-110300843</link>
<guid isPermaLink="true">https://6ix.com/company/conmed-corporation/news/conmed-corporation-appoints-laverne-council-110300843</guid>
<pubDate>Wed, 21 May 2025 11:03:00 GMT</pubDate>
<description>LARGO, Fla., May 21, 2025--CONMED Corporation (NYSE: CNMD) today announced that LaVerne Council has been appointed to succeed Martha Goldberg Aronson as the new Independent Chair of its Board of Directors, effective May 21, 2025.</description>
</item>
<item>
<title>CONMED Corporation Announces First Quarter 2025 Financial Results</title>
<link>https://6ix.com/company/conmed-corporation/news/conmed-corporation-announces-first-quarter-200500096</link>
<guid isPermaLink="true">https://6ix.com/company/conmed-corporation/news/conmed-corporation-announces-first-quarter-200500096</guid>
<pubDate>Wed, 30 Apr 2025 20:05:00 GMT</pubDate>
<description>LARGO, Fla., April 30, 2025--CONMED Corporation (NYSE: CNMD) today announced financial results for the first quarter ended March 31, 2025.</description>
</item>
<item>
<title>CONMED Corporation to Announce First Quarter 2025 Financial Results on April 30, 2025</title>
<link>https://6ix.com/company/conmed-corporation/news/conmed-corporation-announce-first-quarter-200500602</link>
<guid isPermaLink="true">https://6ix.com/company/conmed-corporation/news/conmed-corporation-announce-first-quarter-200500602</guid>
<pubDate>Wed, 02 Apr 2025 20:05:00 GMT</pubDate>
<description>LARGO, Fla., April 02, 2025--CONMED Corporation (NYSE: CNMD) today announced that it will report financial results for the first quarter 2025 after the market close on Wednesday, April 30, 2025. The Company’s management will host a conference call at 4:30 p.m. ET that same day to discuss the results.</description>
</item>
<item>
<title>CONMED Corporation Adds Mark Kaye to its Board of Directors</title>
<link>https://6ix.com/company/conmed-corporation/news/conmed-corporation-adds-mark-kaye-120300266</link>
<guid isPermaLink="true">https://6ix.com/company/conmed-corporation/news/conmed-corporation-adds-mark-kaye-120300266</guid>
<pubDate>Tue, 25 Feb 2025 12:03:00 GMT</pubDate>
<description>LARGO, Fla., February 25, 2025--CONMED Corporation (NYSE: CNMD) today announced that Mark Kaye will be joining its Board of Directors effective February 24th, 2025.</description>
</item>
</channel>
</rss>